Peripheral, blood-derived samples are more accessible than tumor tissues, so we utilized single cell RNA-sequencing (scRNAseq) of PBMC samples as a highly sensitive orthogonal technique to identify and characterize rare circulating immune cells that express LAG-3. This evidence concerns the gene LAG3 and neoplasm.